MediciNova, Inc. (MNOV)

1.45 -0.01 (-0.68%) USD  |  NASDAQ  |  Apr 20, 11:28
More

MediciNova SG&A Expense (Quarterly) : 1.554M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for MNOV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Biogen, Inc. 682.50M
Cytokinetics, Inc. 91.72M
Ionis Pharmaceuticals, Inc. 130.00M
Aldeyra Therapeutics, Inc. 2.364M
Amylyx Pharmaceuticals, Inc. 15.39M